Financials

News Ideas Minds Technicals Forecast

CRTHF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CARSGEN THERAPEUTICS HLDGS LTD. operating, investing, and financing activities

CRTHF free cash flow for H2 23 is -36.88 M USD. For 2023, CRTHF free cash flow was -58.88 M USD and operating cash flow was -57.63 M USD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—